Summary
76 / 100 · Bulios Score
What speaks for it
- Revenue grew by 47% a year over the last 3 years.
- It earns 25 USD a year on every 100 USD of invested capital.
- It holds more cash than debt: $240.3M against $15.0M.
- Out of every 100 USD of revenue, 15 USD is left as net profit.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 39.7 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 34% a year over 5 years. Over the last 3 years it grew by 47% a year.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 57 USD
- Research and development 0.3 USD
- Sales and administration 25 USD
- Taxes and other 2.3 USD
- Net profit 15 USD
Net profit, industry median (Information Technology Services) 6.0 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 4
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $120 is 127% above today's price. 67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- DDS 88%
- Agility 9.3%
- Synodex 2.9%
By region
- UNITED STATES 87%
- CANADA 4.8%
- UNITED KINGDOM 4.3%
- NETHERLANDS 3.5%
DDS brings in 88% of revenue.
Segments in detail